Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
Go back to Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib| (NASDAQ: APLM) | Delayed: 17.35 -0.13 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.48 | 52 Week High | $ | |||
| Open | $17.20 | 52 Week Low | $ | |||
| Day High | $17.80 | P/E | N/A | |||
| Day Low | $17.10 | EPS | $ | |||
| Volume | 3,563 | |||||
| (NASDAQ: APLMW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 17,025 | |||||
